EGFR and nasopharyngeal carcinoma: Although all cell lines in our study were EBV negative, further clinical studies are warranted to determine whether EGFR up‐regulation and enrichment of EGFR in EVs are modulated by EBV status and LMP1 levels in NPC patients with distant metastases.